A research team from the Perelman School of Medicine at the University of Pennsylvania has discovered that Prg4+ stem cells in skeletal muscle can differentiate into osteoblasts, significantly promoting fracture repair. The study was published in the Proceedings of the National Academy of Sciences (PNAS) and offers new insights for treating severe fractures.

Through mouse experiments, the research team confirmed that Prg4+ stem cells rapidly migrate to fracture sites and differentiate into various repair cells, including chondrocytes and osteoblasts. Senior author Professor Ling Qin stated: “This approach harnesses the body’s own repair mechanisms, making the healing process more efficient.” The experiments showed that when these stem cells were artificially disrupted, bone repair speed was markedly slowed.

This discovery holds significant clinical importance for severe injuries such as open fractures. Collaborating researcher Dr. Jaimo Ahn noted: “This mechanism may play a critical role in areas with less muscle, such as the knee joint, as well as in the treatment of elderly patients.” The research team is currently exploring ways to enhance repair effects through growth factors or direct injection of stem cells.

The study breaks through the traditional theoretical limitations of periosteal stem cell repair and is the first to confirm that muscle stem cells can differentiate into osteoblasts. The team plans to further investigate the repair potential of other types of stem cells to expand the scope of clinical applications.